Addendum. 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care 2020;43(Suppl. 1):S89–S97
The DOI matches its Crossref record; the references it cites are not checked yet.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Historically, most older anti-obesity medications approved by the FDA have resulted in modest placebo-adjusted weight loss, ranging from approximately 3 to 8.6%.”
Citations
Cites
U.S. Food and Drug Administration . FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market. Potential risk of cancer outweighs the benefits. 13 February 2020 [FDA Drug Safety Communication]. Available from https://www.fda.gov/drugs/drug-safety-and-availabi
(n.d.)
Unresolved
Cited by
Aldawsari, M., Almadani, F. A., Almuhammadi, N., Algabsani, S., Alamro, Y., & Aldhwayan, M. (2023) · Diabetes, Metabolic Syndrome and Obesity · doi:10.2147/dmso.s387116 · Cited by 115
Qin, W., Yang, J., Ni, Y., Deng, C., Ruan, Q., Ruan, J., Zhou, P., & Duan, K. (2024) · Endocrine · doi:10.1007/s12020-024-03896-z · Cited by 55
“Furthermore, some of these medications were limited by the severity of their side effects [26].”
BackgroundSon, C., Makino, H., Kasahara, M., Tanaka, T., Nishimura, K., Taneda, S., Nishimura, T., Kasama, S., Ogawa, Y., Miyamoto, Y., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109037 · Cited by 22
The Risks of Polycystic Ovary Syndrome and Diabetes Vary by Ethnic Subgroup Among Young Asian Women
Guo, L., Gordon, N. P., Chandra, M., Dayo, O. M., & Lo, J. C.-M. (2021) · Diabetes Care · doi:10.2337/dc21-0373 · Cited by 15
Barana, L., Colleluori, G., Sulpizi, M. T., Ortenzi, K., Farano, L., Fanelli, C. G., Calafiore, R., Ragione, L. D., & Pampanelli, S. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01085-1 · Cited by 2
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-06-05
- Volume
- 43
- Issue
- 8
- Pages
- 1980-1980
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4206507936
- Semantic Scholar
- a834e338afdaf0894ec4f44f3396a1640a08cfdc
- Cited by
- 7
- References
- 1
- Citations by year
- 2024: 2 · 2022: 2 · 2021: 3
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- obesity treatment, type 2 diabetes, bariatric surgery, weight loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Addendum. 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care 2020;43(Suppl. 1):S89–S97. https://app.cochat.ai/papers/10.2337/dc20-ad08b
- The paper
- American Diabetes Association. (2020). Addendum. 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care 2020;43(Suppl. 1):S89–S97. Diabetes Care. https://doi.org/10.2337/dc20-ad08b
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.